Arvinas (ARVN) Current Assets (2017 - 2026)
Arvinas' (ARVN) quarterly Current Assets came in at $630.7 million in Q1 2026, down 35.62% year-on-year from $979.7 million in Q1 2025, and down 9.99% quarter-over-quarter from $700.7 million in Q4 2025.
Arvinas (ARVN) Current Assets (2017 - 2026) Analysis & Trends
Arvinas' Current Assets history runs 10 years deep, the most recent figure standing at $630.7 million for Q1 2026.
- On a quarterly basis, Current Assets fell 35.62% year-over-year to $630.7 million in Q1 2026; TTM through Mar 2026 was $630.7 million, a 35.62% decrease from a year earlier, with the FY2025 full-year figure at $700.7 million, down 34.35% from the prior year.
- Current Assets fell to $630.7 million in Q1 2026 per ARVN's latest filing, from $700.7 million in the prior quarter.
- Across five years, Current Assets topped out at $1.5 billion in Q1 2022 and bottomed at $630.7 million in Q1 2026.
- The 5-year median for Current Assets is $1.1 billion (2023), against an average of $1.1 billion.
- Across the five-year window, Current Assets surged 119.26% in 2022 and tumbled 35.62% in 2026, its largest moves.
- Year by year, Current Assets stood at $1.2 billion in 2022, then climbed by 3.23% to $1.3 billion in 2023, then fell by 16.63% to $1.1 billion in 2024, then tumbled by 34.35% to $700.7 million in 2025, then fell by 9.99% to $630.7 million in 2026.
- Per Business Quant, the three latest ARVN Current Assets figures stand at $630.7 million (Q1 2026), $700.7 million (Q4 2025), and $826.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Arvinas | 519.68 Mn | -95.22 Mn | - | 630.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 630.70 Mn |
| Dec 31, 2025 | 700.70 Mn |
| Sep 30, 2025 | 826.30 Mn |
| Jun 30, 2025 | 889.50 Mn |
| Mar 31, 2025 | 979.70 Mn |
| Dec 31, 2024 | 1.07 Bn |
| Sep 30, 2024 | 1.15 Bn |
| Jun 30, 2024 | 1.26 Bn |
| Mar 31, 2024 | 1.19 Bn |
| Dec 31, 2023 | 1.28 Bn |
| Sep 30, 2023 | 1.03 Bn |
| Jun 30, 2023 | 1.06 Bn |
| Mar 31, 2023 | 1.15 Bn |
| Dec 31, 2022 | 1.24 Bn |
| Sep 30, 2022 | 1.30 Bn |
| Jun 30, 2022 | 1.38 Bn |
| Mar 31, 2022 | 1.46 Bn |
| Dec 31, 2021 | 1.55 Bn |
| Sep 30, 2021 | 1.58 Bn |
| Jun 30, 2021 | 627.73 Mn |